- 🟨 The Yellowbrick Road
- Posts
- YB new stock pitches (Tue, Jan 14)
YB new stock pitches (Tue, Jan 14)
Hello!
I’ve just added 41 new pitches to the website.
As always, you can visit the website to see all of the stock pitches and search/filter them at https://www.joinyellowbrick.com (if you are a premium member, make sure to login so you get the most recent pitches).
Thanks for reading!
Connor (founder of Yellowbrick and CEO Watcher)
P.S. - if you want a condensed, links-only view of the stock pitches for faster browsing, you can find it at https://www.joinyellowbrick.com/links
YB PORTFOLIO
The YB Tracking Portfolio copies the trades of the top 10 investors (based on the average returns of their previous stock pitches) in our database of 1,000+ investors.
Current returns (started mid-May)
IN CASE YOU MISSED IT
Stock pitches you probably haven’t seen
In 2024, there were 1910 stock pitches added to Yellowbrick that were only pitches one time. I collected 25 of them and shared them on Twitter/X.
Check out the thread below and make sure to like/repost!
In 2024, 1910 stocks were added to the Yellowbrick database that were only pitched once.
Here are 25 stock pitches you probably haven't seen before:
— Yellowbrick Investing (@joinyellowbrick)
6:15 PM • Jan 11, 2025
HIGHLIGHTED PITCHES (FREE)
Author Returns
The below stock pitch is from Triple S Special Situations Investing.
Upgrade to Yellowbrick Road Premium to unlock the historic returns for all authors.
BLOG POST - Triple S Special Situations Investing
CVSG: A special sit with 2x potential
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through Veterinary Practices, Laboratories, Crematoria, and Online Retail Business segments.
Ticker: CVSG.L | Price: GBp 818 | Price Target: GBp 1646
Market Cap: GBp 516M | Timeframe: 6-12 months
🐶 Veterinary Group | 🔄 Turnaround | 📈 Bullish Idea
I use Interactive Brokers link to trade international and OTC stocks (if you can’t trade them in your current brokerage)
CVS Group plc (CVSG.L), a UK veterinary group, has faced recent challenges due to a CMA review and a cyber incident, but its fundamentals remain strong. FY2024 saw revenue growth of 9.9% to £647.3 million and adjusted EBITDA increase of 4.7% to £127.3 million, maintaining a 19.7% margin. The company has a comfortable leverage of 1.54x with £168 million in net debt. CVSG is expanding into Australia with 22 new practices, offsetting UK uncertainty. The CMA investigation, expected to conclude by late 2025, is likely to result in moderate changes rather than drastic measures. The company's cloud system rollout post-cyber attack is expected to bring long-term benefits. The pet sector's resilience to economic downturns and CVSG's strong financials position it well for growth. Investors willing to weather short-term volatility may benefit from a potential re-rating once the CMA process concludes, with the stock poised for recovery by year-end.
Read the full article here. Read time: 3 min
Share this stock pitch:
https://www.joinyellowbrick.com/sp/15526/?ref=PLACEHOLDER
Author Returns
The below stock pitch is from Halvio Capital.
Upgrade to Yellowbrick Road Premium to unlock the historic returns for all authors.
FUND LETTER - Halvio Capital
Investment Idea: Citizens Bancshares Corporation (CZBS)
Citizens Bancshares Corporation operates as the holding company for Citizens Trust Bank that provides various commercial banking services to individual and corporate customers. The company offers checking and savings accounts; and demand and money market deposits.
Ticker: CZBS | Price: $51.50 | Price Target: $124.40 (+142%)
Market Cap: $127M | Timeframe: N/A
🏦 Bank | 📈 Bullish Idea
Citizens Bancshares Corporation (CZBS) is a $93m market cap bank trading at an estimated 2025 7x P/E and 0.62x Adjusted TBV, with potential for a 17% adjusted ROE in 2025. The bank received $95.7m in ECIP funding, significantly overcapitalizing it. CZBS has a strong deposit franchise with a low 0.36% cost of deposits in 2023. The bank's loan portfolio is 71% commercial loans, with a yield of 6% in 2023. CZBS has robust capital ratios, including a 40% Tier 1 ratio and 15% CET1. Management owns 31% of the company and has been buying back shares aggressively. Potential catalysts include M&A, buybacks, uplisting, and retiring ECIP preferred below par. Risks involve recession impacts on loans, interest rate shocks, and potential bank runs, though CZBS is highly liquid. The stock offers 53-140% upside potential based on 11-13x 2025 P/E or 1-1.48x 2025 TBV multiples, not accounting for potential M&A or buybacks.
Read the full article here. Read time: 14 min
Share this stock pitch:
https://www.joinyellowbrick.com/sp/15529/?ref=PLACEHOLDER
Author Returns
The below stock pitch is from @richtrades100.
Upgrade to Yellowbrick Road Premium to unlock the historic returns for all authors.
TWITTER - @richtrades100
JELD-WEN Positioned to Capitalize on Los Angeles Fire Rebuild Opportunity
JELD-WEN Holding, Inc. designs, manufactures, and sells wood, metal, and composite materials doors, windows, and related building products in North America and Europe.
Ticker: JELD | Price: $8.75 | Price Target: N/A
Market Cap: $745M | Timeframe: N/A
🏗️ Building Products | 📈 Bullish Idea
JELD-WEN Holding, Inc. (JELD) could potentially benefit from the Los Angeles fires rebuild, estimated to cost between $135 billion and $202.5 billion. Assuming windows and doors make up 5-10% of rebuild costs, JELD could capture 6-8% of an $8.44 billion to $20.25 billion market. This translates to potential revenue of $506 million to $1.62 billion over a 5-year period, with estimated cumulative EBITDA ranging from $472.5 million to $1.7 billion. The company could recognize 15-30% of total estimated revenue in the first year, with the remainder spread over subsequent years. Potential EBITDA per share could range from $6.49 to $23.37, based on varying market capture and EBITDA margins. JELD's distribution network, economies of scale, and brand recognition could provide advantages in capturing this market. Value-oriented investor Turtle Creek has recognized potential value in JELD.
Read the full article here. Read time: 2 min
Share this stock pitch:
https://www.joinyellowbrick.com/sp/15533/?ref=PLACEHOLDER
Find all of the stock pitches on https://joinyellowbrick.com (30-day delay for free subscribers).
Unlock all stock pitches (plus historic author returns and Elite Investor Feeds) by upgrading to Yellowbrick Premium.
THE REST OF THE PITCHES
To get access to all of the stock pitches, upgrade to Yellowbrick Road Premium. If part of your job is idea generation (either for your personal account or a fund), it’s a no-brainer.
🎁 REFERRAL PROGRAM 🎁
Use your unique URL below or the share URL for any of the stock pitches to unlock insanely valuable awards.
Premium members have access to these awards here.
THAT’S ALL FOLKS
Thank you so much for reading today’s email! Your support is the only way I can write this email for free every day.
Give me feedback in the poll below and share the newsletter with other investors if you find it useful!
Connor
*Follow Yellowbrick on Twitter at @joinyellowbrick
How would you rate today's newsletter?If you vote 1 or 3 stars, please leave a comment with what you didn't like so I can improve it! |
Reply